Health & Biotech
Health & Biotech
The total market cap of small cap ASX medtechs grew 57pc in the past year
Health & Biotech
Dr Boreham’s Crucible: Is Cynata Therapeutics’ Fujifilm partnership all puff and no blow?
Health & Biotech
Epilepsy and dementia sufferers across the globe to benefit from new MGC Pharma agreements
Health & Biotech
Health: Wound device maker PolyNovo just struck a deal with the US military
Health & Biotech
Health: G Medical is close to listing on the NASDAQ and Hong Kong exchanges
Health & Biotech
Regeneus ramps up global focus with addition of industry leaders
Health & Biotech
Creso Pharma moves to Australia with distribution deal and import licence
Health & Biotech
Health: Funding from ScoMo sends PainChek rocketing 91pc to seven-month high
Health & Biotech
The Pot Seat: Emerald’s Stewart Washer says they’re listing this year
Health & Biotech
Rhinomed breathing easy thanks to strong March quarter, shares rise 26pc
Health & Biotech
How the biotech community is fighting back against superbugs
Health & Biotech
Dr Boreham’s Crucible: Sienna’s first acquisition opens up the field of play
Health & Biotech
Health: Elixinol pivots to pet pot treats, nabs 25pc stake in US hemp manufacturer
Health & Biotech
ResApp trial sends shares up 36pc as rollercoaster ride continues
Health & Biotech
Dr Boreham’s Crucible: Are China and the US finally waking up to Compumedics?
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.